Complex Size: 900 KDa
Potency: KFDA/In-House 80-125/95-115
Endotoxin Level(EU/Vial): KFDA/In-House <1.0/0.175
Molsture: Less than 3%
Explration: 24months from the date of manufacture
|Efficacy Effects||Temporary improvement in the appearance of moderate to severe glabella wrinkles associated with corrugator musleand/or procerus muscle activities|
|Main Ingredients||Clostridium botulinum toxin type A (standard) -100 units|
|Description||White or light yellow lyophilizate in a colorless transparent vial that becomes clear and transparent when dissolved in physiological saline|
|Classification||White or light yellow lyophillizate in a colorless transparent vial that becomes clear and transparent when dissolved in physiological saline|
Ingredient & Content
-In one vial-
100 units of Clostridium botulinum toxin type A (standard), serum albumin (vitality), sodium chloride (USP)
Temporary improvement in the appearance of moderate to severe glabella wrinkles (vertical lines between the eyebrows) associated with corrugator muscle and/or procerus muscle activities, in adults aged between 20 to 65.
Sealed container, refrigerated (2 ~ 8 C) Storage
Date of Use
36 months from date of manufacture
Resume normal work right away
Just by few tiny injections
Effects visible after one administration, starting from 2 weeks after injection, and peaks around 3~4 weeks.
Painless even when used without aenesthetic
Effects last for 6~12 months
Approved by Health Authorities with over 8 years’ clinical practices.
There is the possibility of reactions at the site of an injection, and effects beyond the injection site, including but not limited to asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. Serious hypersensitivity has been reported as rare.
There is a caution for people with pre-existing neuromuscular disorders, and for those with corneal exposure and ulceration in blepharospasm.
Botulium Toxin Type A is not to be administered at all if a patient has a known allergy to any of the ingredients, or if the patients have neuromuscular junctional disorders or known to have adverse reactions.
To preserve results achieved after a treatment with this Botulinum Toxin Type A injectable, patients need to undergo maintenance injection procedure
Hipretty PDO Thread
Younsofill Dermal Fillers
Cindella + Luthione + VitaminC